Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Areplivir IV in Hospitalized COVID-19 Patients
NCT05185284Phase 3Completed
- Sponsor
- Promomed
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Promomed. Started Aug 2021; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05185284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05185284.